Home Imutrex Tablets (Methotrexate) 25mg Pack of 100
Imutrex Tablets (Methotrexate) 25mg Pack of 100 – Available in Pakistan
Imutrex 25mg methotrexate back of pack – View Product Detail
Imutrex tablets blister pack cytotoxic prescription medicine – View Product Detail
Imutrex Tablets (Methotrexate) 25mg Pack of 100 – Available in Pakistan
Imutrex 25mg methotrexate back of pack – View Product Detail
Imutrex tablets blister pack cytotoxic prescription medicine – View Product Detail

Imutrex Tablets (Methotrexate) 25mg Pack of 100

Imutrex Tablets contain Methotrexate 25mg, a cytotoxic folic acid antagonist that irreversibly inhibits dihydrofolate reductase to slow nucleic acid synthesis in rapidly dividing cells. Used under specialist supervision for acute lymphoblastic leukaemia, choriocarcinoma, lymphoma, osteogenic sarcoma, severe psoriasis and other malignant or autoimmune conditions. Pregnancy is strictly contraindicated due to high teratogenic and abortifacient risk. Folate co-prescription is standard. Prescription required. Each pack contains 100 tablets.

Sale price Rs. 995

Pay in 3 Installments of

Rs.

381

Availability: In stock SKU: DER000000274
Tags: 25mg Acute Lymphoblastic Leukemia ALL Antimetabolite Blood Counts Bone Marrow Depression Burkitts Lymphoma Cancer Choriocarcinoma Cytotoxic Dosage Adjustments Hematological Assessments Imutrex Kidney Function Lymphosarcoma Malignant Diseases Methotrexate Osteogenic Sarcoma Psoriasis Renal Function Side Effects Skin Cancer Toxicity Tumors
Imutrex Tablets (Methotrexate) 25mg Pack of 100 – Available in Pakistan

Imutrex Tablets (methotrexate) 25mg Pack of 100

Rs. 995

Managing Malignant Diseases with Imutrex (Methotrexate)

Imutrex (Methotrexate) 25mg tablets, an essential cytotoxic
antimetabolite, play a pivotal role in combating malignant tissue with high
cell turnover By irreversibly binding with dihydrofolate reductase and
inhibiting nucleic acid synthesis, Imutrex effectively hinders cell division
While it targets malignant cells, it may adversely affect other rapidly
dividing normal tissues, necessitating careful consideration of its usage

Description IMUTREX TABLETS

IMUTREX TABLETS mode of action revolves around its function as a
folic acid antagonist, leading to a deficiency that hinders nucleic acid
synthesis Rapidly absorbed and predominantly excreted through the kidneys, its
effectiveness depends on factors such as renal function and the dose
administered This potent medication finds utility in managing various malignant
diseases, including acute lymphoblastic leukemia, choriocarcinoma, and
psoriasis

Indications and Contraindications

IMUTREX TABLETS is particularly effective in the treatment of
lymphosarcoma, Burkitt's lymphoma, osteogenic sarcoma, and tumors in various
organs However, it is contraindicated in pregnant women, those with poor
nutrition, serious renal or liver disorders, and individuals with bone marrow
hypoplasia or blood-related issues Close monitoring and regular blood counts
are crucial during Imutrex therapy, and adjustments to the dosage may be
necessary based on observed toxicity

Undesirable Effects and Precautions

Patients undergoing Imutrex therapy may experience a range
of adverse effects, including gastrointestinal disturbances, bone marrow
depression, and an increased susceptibility to long bone fractures Regular
hematological assessments and close vigilance for signs of toxicity are
imperative Caution is advised for patients with impaired renal function,
infections, peptic ulcers, or debility Dosage adjustments should be made
accordingly to mitigate the potential risks associated with its usage

Dosage Guidelines IMUTREX TABLETS

For acute lymphoblastic leukemia, the recommended oral
dosage is 33 mg of Imutrex per M2 of body surface daily, in combination with
prednisolone The maintenance dosage for achieving remission is typically 20-30
mg/M2 of body surface orally twice a week In the case of Mycosis Fungoides, the
dosage may range from 25 to 10 mg orally daily for several weeks or months,
with appropriate adjustments as necessary

Given the potential risks and benefits, the usage of Imutrex
necessitates close medical supervision and careful consideration of the
patient's overall healthcare and condition


Usage & Benefits

- Established cytotoxic for haematological and solid tumours
- Manages severe, treatment-resistant psoriasis
- Reduces inflammation in refractory rheumatoid and other autoimmune disease
- 25mg strength suited to oncology and weekly autoimmune regimens
- Folate antagonist with well-defined monitoring framework
- 100-tablet pack for long-term specialist therapy
- Authentic Crystolite supply with prescription verification

How To Use

Strictly as prescribed by your oncologist or specialist. Oncology dosing is calculated by body surface area; autoimmune use is typically once-weekly dosing, never daily, to avoid fatal overdose. Folic acid is co-prescribed. Mandatory monitoring: complete blood count, renal and liver function before each cycle. Pregnancy is absolutely contraindicated; effective contraception is required for both partners during and after treatment. Stop and seek urgent care for breathlessness, mouth ulcers, fever, bruising or jaundice. Store at 15-30°C, out of reach of children. Prescription required.

FAQs

What is Imutrex used for?

It is prescription Methotrexate for cancers such as leukaemia and lymphoma, severe psoriasis and certain autoimmune disorders.

Can I take it during pregnancy?

No. Methotrexate is strictly contraindicated in pregnancy due to teratogenic and fetal death risk.

Why is dosing weekly for autoimmune conditions?

Daily dosing in autoimmune use can cause fatal bone marrow toxicity; only oncology protocols use higher frequency.

Do I need folic acid with Methotrexate?

Yes, folate supplementation reduces side effects such as mouth ulcers and liver toxicity in long-term use.

What monitoring is required?

Regular CBC, liver and renal tests are mandatory and any infection or unusual bleeding should be reported immediately.